This is clinically significant because metabolic dysfunction-associated steatotic liver disease (MASLD) previously known as non-alcoholic fatty liver disease (NAFLD) is estimated to affect approximately 2530% of adults in the UK (British Liver Trust), and can progress to cirrhosis and liver failure if untreated
Rybelsus is commercially manufactured and not available as a compounded medication
Schedule your next appointment and start your weight loss journey today!
Dulaglutide (Trulicity) is another GLP-1 receptor agonist, but is licensed only for type 2 diabetes in the UK, not for weight management
Also involved in OA are many other forms of PCD, including autophagy, pyroptosis, apoptosis, cuproptosis, and necroptosis
This clinic isnt offering another trendy diet or gimmicky supplement